Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
10/2008
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2007139968A3 Triazole compounds that modulate hsp90 activity
10/02/2008US20080242860 Silver halide color photographic light-sensitive material and image formation method using the same, silver halide emulsion, reducing compound having group adsorptive to silver halide and method for producing the same
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080241591 Organic electroluminescence device and phenylenediamine derivative
10/01/2008EP1975157A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP
10/01/2008EP1973890A2 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/01/2008EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101273988A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
10/01/2008CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists
09/2008
09/30/2008CA2355470C Benzoheterocycles and their use as mek inhibitors
09/30/2008CA2314009C Triazole and imidazole derivatives
09/25/2008WO2008115154A1 Catalyst immobilization on siliceous mesocellular foam via click chemistry
09/25/2008US20080234481 Forming salts such as tartrate or mandelate ; chemical intermediate
09/25/2008US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
09/25/2008US20080234252 2-[4-(4-Chlorophenyl)-5-(methoxymethyl)-4H-1,2,4-triazol-3-yl]isoindoline; vasopressin antagonists; dysmenorrhea, Alzheimer's disease, anorexia nervosa, anxiety, anxiety disorder, asthma, atherosclerosis, autism, cardiovascular disease
09/24/2008CN101273021A Selected CGRP antagonists, methods for the production thereof and their use as medicaments
09/23/2008US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/17/2008EP1791825B1 Benzoyl-substituted serine amides
09/17/2008EP1392639B1 Pyruvate derivatives
09/17/2008EP1272827B1 Analyte detection
09/17/2008CN100418956C Process for preparation of aryltriazolinones
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/12/2008WO2008107322A1 Indole, benzimidazole or benzotriazole derivatives including a piperidine or piperazine core as anti-neoplasic agents or cell proliferation inhibitors
09/12/2008WO2008075955A3 Process for the preparation of 1,4,5-trisubstituted triazoles and 3,4,5-trisubstituted triazoles
09/12/2008WO2008073461A3 Ion channel modulators
09/12/2008WO2007134678A3 Triazole derivatives ii
09/11/2008US20080221675 Functionalized phosphine oxide photoinitiators having an attached benzotriazole or hydroxyphenylbenzotriazole ring; capable of initiating free radical polymerization; contact and intraocular lenses
09/10/2008EP1966282A1 Polymer structure reacting with keratin, synthesis and use thereof
09/10/2008EP1966167A1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
09/10/2008EP1966166A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS
09/10/2008EP1965644A1 Novel herbicides
09/10/2008EP1362856B1 Water-soluble triazole fungicide
09/10/2008CN101260081A Preparation method for N-arylazoles compounds
09/04/2008WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists
09/04/2008WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers
09/04/2008US20080214831 Copper-catalysed ligation of azides and acetylenes
09/04/2008US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds
09/04/2008US20080214622 Substituted Triazole Derivatives As Oxytocin Antagonists
09/04/2008US20080214532 Carboxanilides as Microbiocides
09/04/2008US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/04/2008CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers
09/03/2008EP1964848A1 Radiofluorination methods
09/03/2008EP1962864A1 Antibacterial agents
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420062 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
09/02/2008US7419513 Benzotriazole/HALS molecular combinations and compositions stabilized therewith
08/2008
08/28/2008WO2008103353A1 Triazole compounds that modulate hsp90 activity
08/28/2008WO2008060931A3 Method for preparing fluorinated benzotriazole compounds
08/28/2008WO2007133820A3 Diaryl triazolones as cb1 antagonists
08/28/2008US20080207915 Reacting 3,5-bis(halmethyl)toluene with metal cyanide; cyanation in presence of catalyst; methylation with methyl iodide; heating with sodium or potassium salt of 1,2,4-triazole
08/28/2008CA2678846A1 Peroxisome proliferator activated receptor modulators
08/27/2008EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors
08/27/2008EP1455781B1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer
08/27/2008CN101253160A Improved process for the preparation of letrozole
08/27/2008CN101250163A Process for producing epoxytriazole compound and intermediate therefor
08/26/2008US7417151 Boron-based organic cations and related methods
08/26/2008CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent
08/21/2008WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
08/21/2008WO2007139955A3 Triazole compounds that modulate hsp90 activity
08/21/2008US20080200551 Flourene Derivative
08/21/2008US20080200528 Derivatives of a 1-Phenyltriazole
08/21/2008US20080200519 5-Amino-1-(4-fluorophenyl)-N-[6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-5-methoxy-4,4-dimethyl-2-(trifluoromethyl)naphthalene-1-yl]-1H-pyrazole-4-carboxamide; selectivity to glucocorticoid receptor; fewer side effect; inhibit secretion of cytokine IL-8 into monocyte cell line THP-1 triggered by lipopolysacch
08/21/2008US20080200518 insecticides, acaricides; crops, foods and goods; a urea, a thiourea or a guanidine; ring is imidazole or 1,2,4-triazole or tetrazole; 4-{4-[4-(3,3-Dichloroprop-2-enyloxy)-2,6-dichlorophenoxy]butyl}-1-[4-(trifluoromethyl)phenyl]-1,2,4-triazolin-5-one; a 1,2,3,4-tetrazolin-5-one
08/21/2008US20080200462 Substituted pyrazole and triazole compounds as ksp inhibitors
08/20/2008EP1958934A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
08/20/2008EP1957459A2 Iminopropene compound and use thereof
08/19/2008US7414134 B1 bradykinin receptor antagonists
08/14/2008WO2008097640A2 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
08/14/2008US20080194656 Benzotriazole Derivatives as Cannabinoid Receptor Antagonists
08/14/2008CA2677481A1 Triazole compounds that modulate hsp90 activity
08/13/2008CN101239932A Preparation of 3,5-di(2-cyano-isopropyl)-toluene
08/12/2008US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives
08/12/2008US7410933 Substituted thiene-3-ylsulphonylamino(thio)carbonyl-triazolin(thi)ones
08/07/2008WO2008094617A2 Crystalline forms of deferasirox
08/07/2008WO2008076225A3 Non-nucleoside reverse transcriptase inhibitors
08/07/2008US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist;
08/07/2008US20080188474 Substituted triazoles useful as axl inhibitors
08/07/2008US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine
08/07/2008US20080187978 Anti-inflammatory medicaments
08/07/2008DE102007004698A1 Verbindungen enthaltend Organofluorochlorophosphatanionen Compounds containing Organofluorochlorophosphatanionen
08/07/2008DE102006053594B4 Verfahren zur Reinigung von Letrozol A process for purifying letrozole
08/06/2008EP1951690A1 Heterocyclic cetp inhibitors
08/06/2008EP1951689A1 P2x7 receptor antagonists and methods of use
08/06/2008EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008CN100408036C Use of anastrozole for the treatment of post-menopausal women having early breast cancer
08/05/2008US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407516 variety of molecules used as oxidation bases and couplers allows a wide range of colors to be obtained; hair dye
08/05/2008CA2337586C Alkylation process and novel hydroxyphenylbenztriazoles
07/2008
07/31/2008WO2008090565A1 Novel thermodynamically stable polymorphic form-l of letrozole
07/31/2008WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors
07/31/2008WO2006135627A3 Inhibitors of akt activity
07/31/2008US20080182862 e.g. 1-(isoquinolin-1-yl)-N3-(2-(pyrrolidin-1-ylmethyl)benzo[d]oxazol-5-yl)-1H-1,2,4-triazole-3,5-diamine; protein tyrosine kinase receptor Axl inhibitor; bioassay; antiinflammatory, anticarcinogenic agent, anticoagulant; rheumatoid arthritis, vascular disease, diabetic retinopathy, osteoporosis
07/31/2008US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer
07/31/2008US20080182837 New chemical compounds
07/30/2008CN101233100A An impurity of anastrozole intermediate, and uses thereof
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 178